Bölümler
-
Bethany, Molly and Katie talk through all aspects of Rh Immune Globulin (RhOGAM, WinRho, RhIG). They cover the history, how it’s made, its safety profile, understanding the RhIG shortage, and public health controversy. The women provide information for Rh negative women who are deciding whether or not to accept the RhIG injection for a pregnancy.
Do you live in the U.S. and have Anti-D antibodies? You could be paid more than $100 per plasma donation (up to twice a week) with reimbursement for travel to a donation center. E-mail us at [email protected] and Bethany, Katie or Molly will respond to confirm your potential eligibility and refer you directly to our personal contact at Kedrion.
Learn about Kedrion, the manufacturer of RhoGAM: https://www.kedrion.com/therapies/
RhoGAM website: https://www.rhogam.com/
Donate to AHF: Allo Hope Donate
AHF Merch: Allo Hope Merch
Watch this episode on YouTube: Allo Hope on YouTube
Join the AHF patient support group:
AHF Support Facebook
-
Bethany, Molly and Katie talk through differences in HDFN care continent by continent. They review country-specific research, practice patterns, and patient stories.
Donate to AHF: Allo Hope Donate
AHF Merch: Allo Hope Merch
Watch this episode on YouTube: Allo Hope on YouTube
Join the AHF patient support group: AHF Support Facebook
Cross-matching for Kell in Netherlands: Luken JS, Folman CC, Lukens MV, Meekers JH, Ligthart PC, Schonewille H, Zwaginga JJ, Janssen MP, van Der Schoot CE, van der Bom JG, de Haas M. Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: a nation‐wide policy change evaluation study in the Netherlands. Transfusion. 2021 Mar;61(3):713-21.
Iceland study: Gudlaugsson B, Hjartardottir H, Svansdottir G, Gudmundsdottir G, Kjartansson S, Jonsson T, Gudmundsson S, Halldorsdottir AM. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: A nation‐wide population study prior to routine antenatal anti‐D prophylaxis. Transfusion. 2020 Jan;60(1):175-83.
South Korea study: Yang EJ, Shin KH, Song D, Lee SM, Kim IS, Kim HH, Lee HJ. Prevalence of unexpected antibodies in pregnant Korean women and neonatal outcomes. The Korean Journal of Blood Transfusion. 2019 Apr 30;30(1):23-32.
Saudi Arabia study: Alkhaibary A, Ali M, Tulbah M, Al-Nemer M, Khan RM, Al Mugbel M, Al Sahan N, Hassounah MM, Alshammari W, Kurdi WI. Complications of intravascular intrauterine transfusion for Rh alloimmunization. Annals of Saudi Medicine. 2021 Nov;41(6):313-7.
Iran study: Niroomanesh S, Dadgar S, Shirazi M, Sharbaf FR, Golshahi F. Neonatal outcomes of Rh alloimmunization pregnancy treated with intrauterine transfusion. Med. Sci.. 2020;24(101):57-65.
Japan study: Mizuuchi M, Murotsuki J, Ishii K, Yamamoto R, Sasahara J, Wada S, Takahashi Y, Nakata M, Murakoshi T, Sago H. Nationwide survey of intrauterine blood transfusion for fetal anemia in Japan. Journal of Obstetrics and Gynaecology Research. 2021 Jun;47(6):2076-81.
Canada study: Jackson ME, Baker JM. Hemolytic disease of the fetus and newborn: historical and current state. Clinics in Laboratory Medicine. 2021 Mar 1;41(1):133-51.
Brazil study: Pares DB, Pacheco GH, Lobo GA, Araujo Júnior E. Intrauterine Transfusion for Rhesus Alloimmunization: A Historical Retrospective Cohort from A Single Reference Center in Brazil. Journal of Clinical Medicine. 2024 Feb 28;13(5):1362.
-
Eksik bölüm mü var?
-
On listener request, Bethany and Molly dedicate an episode to the friends and family of the alloimmunized mother. They reintroduce themselves, explain alloimmunization and HDFN and what to expect from an alloimmunized pregnancy, and give concrete advice on how to support someone navigating this disease.
Read a description of HDFN on the National Organization for Rare Disorders website written by AHF: NORD: HDFN
Mental health burden in alloimmunized pregnancy: AJOG: Mental Health and HDFN
Donate to AHF: Donate
AHF Merch: Merch
Watch this episode on YouTube: Allo YouTube
Join the AHF patient support group: Facebook Group
www.allohopefoundation.org
-
In true Bethany and Molly fashion, the hosts open with laughing at inappropriate stories and end in happy tears sharing the most heartfelt moments of love and appreciation for each other and this special community. One Tiny Thing is a compilation of patient-provided “tiny things” that happened to them and changed everything.
Bethany and Molly discuss listener answers to these special questions:
What is one tiny thing that could have saved your HDFN baby’s life?
What is one tiny thing that did save your HDFN baby’s life?
What is one tiny thing that someone said to you that changed your perspective on this experience?
Donate to AHF: https://allohopefoundation.org/get-involved/donate/
AHF Merch: https://allo-hope-foundation.myspreadshop.com/
Watch this episode on YouTube: allohope youtube
Join the AHF patient support group:
https://www.facebook.com/groups/antibodiesinpregnancy
-
Bethany and Molly return to record with Dr. Markham, a well-loved maternal fetal medicine specialist who has treated many HDFN babies. They cover many questions submitted by allo moms including:
Does a high titer or low titer mean the baby is antigen positive or negative?
If mom’s antibodies are too low to titer, what does that mean for the rest of the pregnancy?
Is it too risky to pursue another pregnancy with a titer of 2,048?
Is it safe to have an external cephalic version (ECV) for breech babies in alloimmunized pregnancy?
What is the best mode of delivery for an alloimmunized pregnancy?
When should we deliver if the pregnancy didn’t need IUTs? If the pregnancy is low titer?
Can antibodies cause hydrops or death without a high MCA Doppler ultrasound first?
How has a patient made you, the doctor, feel valued?
Can obesity make IUTs more difficult?
The women close with some patient-submitted stories of the most shocking thing that happened during an IUT, with Dr. Markham sharing a hilarious one of her own.
Delivery timing 37-38 weeks: ACOG Medically Indicated Late Term and Early Preterm Deliveries.
Donate to AHF: https://allohopefoundation.org/get-involved/donate/
AHF Merch: https://allo-hope-foundation.myspreadshop.com/
Watch this episode on YouTube:
Join the AHF patient support group:
https://www.facebook.com/groups/antibodiesinpregnancy
-
S3E2: Low Titer Alloimmunized Pregnancies
Over half of alloimmunized pregnancies begin with a low antibody titer, and a portion stay low throughout the pregnancy. Others begin low and later rise to critical levels. This episode is dedicated to management of the low titer pregnancy and how to anticipate a potential change in disease trajectory if titers increase.
Bethany and Molly include management recommendations and stories submitted by low titer moms before transitioning to a special interview with allo mom Amanda, whose pregnancy began as a low titer pregnancy before taking a surprising turn. We meet Amanda in this episode before resuming the second half of her HDFN journey in this season’s final episode, Incredible HDFN Survival Stories.
Key aspects of low titer disease management:
Determine baby’s antigen status if possible. If not possible, monitor as if antigen positive. If the baby is certainly antigen negative, the pregnancy proceeds as normal and there is no need to do anything further beyond standard pregnancy careEstablish care with an MFM and determine up front if this MFM is able to do IUTs on your baby if your disease progresses. If not, have a referral plan set upCheck titers every 4 weeks in the first and second trimester, then every 2 in the third trimesterWeekly fetal assessment beginning at 32 weeks (Nonstress tests and biophysical profiles).Delivery at 37-38 weeksFollow all neonatal recommendations (establish a plan with pediatrician in advance if possible b/c they are likely to be doing the follow-up care) - bilirubin consistent with AAP guidelines which may include daily testing after discharge for a week or more, and hemoglobin/hematocrit weekly for the first six weeks and until hemoglobin/hematocrit increases or is in stable normal range for two consecutive weeksDelivery timing 37-38 weeks: ACOG Medically Indicated Late Term and Early Preterm Deliveries. ACOG Early Delivery Guidlines
AAP guidelines for hyperbilirubinemia after birth: AAP on Hyperbilirubinemia
Undetectable antibodies progressing to severe disease: Dajak S, Stefanović V, Čapkun V. Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first‐trimester screening (CME). Transfusion. 2011 Jul;51(7):1380-8. Undetected Antibodies Research
Amanda’s video blog of her alloimmunized pregnancy journey: Amanda's Video Blog
Donate to AHF: https://allohopefoundation.org/get-involved/donate/
AHF Merch: https://allo-hope-foundation.myspreadshop.com/
Watch this episode on YouTube: https://youtu.be/AA9J1pHPNUA
Join the AHF patient support group:
https://www.facebook.com/groups/antibodiesinpregnancy
-
S3E1: Top 5 Things to Save HDFN Babies
Bethany and Molly begin Season 3 with a review of the episodes ahead before challenging each other to list what they think are Top 5 things that would keep the most HDFN babies safe. The episode takes a turn when they reveal that they have signed themselves up for plenty more than 5 things (listed below).
Donate to AHF: https://allohopefoundation.org/get-involved/donate/AHF Merch: https://allo-hope-foundation.myspreadshop.com/
Watch this episode on YouTube:YouTube The Essential 5
Join the AHF patient support group: https://www.facebook.com/groups/antibodiesinpregnancy
Top 5 Prenatal Things (in no particular order):
Bethany:
Quick referral to MFM (and a list of MFMs worldwide who specialize in treating alloimmunized pregnancies)Preventative medications accessible to all women who need them (Rh immune globulin/RhoGAM; intravenous immune globulin, plasmapheresis for severely affected pregnancies)Weekly, accurate MCA scans beginning at 16-17 weeks for those with critical titers or previously affected babies; for those with early onset severe disease, starting soonerMFMs who collaborate with other experts and refer when necessaryIUTs performed on time, using fetal paralytic meds, by providers with ample experience performing IUTs who know to space and attempt the last IUT at 34-35 weeks if possible(Honorable mention): Referring all women with positive antibody screen to Allo Hope Foundation (Honorable mention): Delivery at 37-38 weeks unless you are certain baby is antigen negativeMolly:
Immediate referral to MFM after positive antibody screenWeekly MCA scans for critical titer/previously affected pregnancies (Weekly MCA recommendation from the group who developed MCA scans: www.academia.edu) Establishing global referral centers for IUTsAn awareness that the seriousness of the disease can change at any time (e.g., low titers can jump up, first pregnancies can be severely affected - will result in closer monitoring)Go in if you notice a change in baby’s movement or something doesn’t feel right about your treatment or monitoringTop 5 Neonatal Things (in no particular order):
Molly:
Establishing neonatal care in advance of delivery (NICU/hematology in cases where pregnancy has needed treatment or high titers; pediatrician for lower titers)Create a fetal care record for your baby (AHF is developing this and it is not yet publicly available: e-mail us at [email protected] if you would like to use a draft version in the interim)Following bilirubin closely after birth and doing a trial off of lights before discharge (AAP hyperbilirubinemia guidelines: aap.org/pediatricsWeekly hemogobin/hematocrit after discharge until consistently trending upward or stable in a healthy range for 2+ weeks (Neonatal management from the Netherlands: research.rug.nlFollow the trend. Do not rely on one laboratory reading. Two readings are needed for a trend. Bili should be trending down; hemoglobin/hematocrit increasing.Bethany:
Continuity of care from MFM to neonatologist to pediatrician to pediatric hematologistTest cord blood at birth (hematocrit/hemoglobin, bilirubin, Direct Coombs Test (DCT))Providers who understand how hemolytic jaundice and hemolytic anemia work (as opposed to newborn jaundice and iron deficiency anemia)Close monitoring and aggressive treatment for hyperbilirubinemia (see AAP guidelines linked above)Follow-up blood tests weekly after hospital discharge -
The Allo Podcast is back for a third season! This season features:
New stories of survival in the most critical of medical situations.Conversations with MFM Dr Kara Markham and Neonatal Specialist Dr Tim Bahr.New information about medical advancements in the treatment of HDFN.A live gender reveal from one of the podcast’s previous guests.And, of course, Bethany Weathersby and Molly Sherwood are back to brighten your day.New episodes begin streaming on Tuesday November 5th. So, shine up your earbuds, get ready to be inspired and empowered, and follow the Allo Podcast wherever fine podcasts are streamed. Or, if you’re looking for some smiling faces and the occasional teary eye, join us over on YouTube.
-
Over the Past 2 seasons Bethany and Molly have discussed the lack of consistent, accessible treatment and the current ways we can treat an alloimmunized mom and her children with HDFN, but on this episode with Dr. Moise we discuss a bright future. Can a simple carbon monoxide reader replace a needle procedure to monitor for anemia? Can a drug stop antibodies from crossing the placenta entirely? We look to the cutting edge of medical treatment for disease that brought these women together.
Guest: Dr. Kenneth J Moise Jr, M.D. Dell Medical School – UT Austin
Director, Comprehensive Fetal Care Center Dell Children’s Medical CenterDONATE TO AHF AFRICA
Episode Topics:
Severity of subsequent alloimmunized pregnanciesIVIG and importance of timely treatmentIdeal newborn management of HDFNAntibody-specific differences in newborn HDFN presentationErythropoietin to prevent or delay need for neonatal transfusionCell free fetal DNA (cffDNA) (Billion To One’s Unity Screen) for fetal antigen typing instead of amniocentesisExhaled carbon monoxide to monitor for newborn anemiaNipocalimab trial updateState of alloimmunization/HDFN in AfricaWhat can you do to help?Links:
Leiden paper on disease severity in subsequent alloimmunized pregnanciesPETIT trial on IVIGLeiden paper on neonatal management of HDFNErythropoietin for newborns with HDFN to delay or reduce need for transfusioncffDNA for fetal antigen statusUtah study on carbon monoxide to detect hemolysisNipocalimab for HDFN:Clinical trial listing (continuously updated)Phase 2 resultsAHF/Dr. Moise live webinar with allo moms on nipocalimabEthiopia studyWorldwide Initiative for the Eradication of Rh DiseaseRhesus Solution Initiative (Nigeria)DONATE TO AHF AFRICAGeneral donation to AHFResearch for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at https://allohopefoundation.org
The Allo Podcast is produced and edited by Media Club.
-
Continuing from last episode, Bethany and Molly listen to Rose Murage’s story. As Rose navigates the final few steps to the United States, she discovers that both the lack of quality care in Kenya and the trauma of her previous pregnancies will follow her to America. But tears of sorrow become tears of joy when she is finally in the hands of a provider who can offer empathetic, quality care, and the world and the podcast welcomes baby Lucas.
Episode themes:
Traveling to another country to receive care for alloimmunization/HDFNSevere HDFN MCA Doppler ultrasound to monitor for fetal anemia Intrauterine blood transfusion (IUT) Emergency c-sectionNICU experience with HDFN babyWelcoming a miracle while coping with the grief of previous lossHopeWhat can you do as a listener?
Please donate to the AHF Africa program. An antibody screen in Kenya costs $5, but most families cannot afford this additional expense. We need $12,000 a year to sustain this program. Learn more about what we do with your donations and make a donation here. Anyone who contributes a $50/month recurring donation will receive quarterly e-mail updates directly from Rose, AHF’s Ambassador to Kenya.Join O Negative Foundation Kenya if you live in Kenya and have a negative blood type.Follow or donate to Rhesus Solution Initiative, a Nigerian NGO dedicated to educating women about their blood type and providing access to Rh immune globulin to prevent alloimmunization.Research for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at https://allohopefoundation.org
The Allo Podcast is produced and edited by https://www.mediaclub.co.
-
This special two-part episode of the Allo Podcast is intended for our regular listeners and for those who are unfamiliar with alloimmunization. A beautiful testament to the grace of humanity, Bethany and Molly sit on the floor of Molly’s bedroom with guest Rose Murage, a native Kenyan with a harrowing pregnancy journey. Rose shares the pain of watching her first two children die tragic, inexplicable deaths. But when Rose reached out to Bethany for help, a new journey began to diagnose Rose with red cell alloimmunization and find a way towards a living baby in a country with limited resources. Join us for the first part of Rose’s story as she tells of her life in Kenya, the short physical lives of Alexis and Max, the obstacles she overcame to seek treatment, and the gift of an American doctor and a network of activists to heal a family.
Definitions for the show notes as they appear in the episode:
Rhogam shot/Rh immune globulin/Anti-D injection: An injection for Rh negative women to help prevent them from developing Anti-D antibodies during pregnancy. This needs to be administered after pregnancy bleeding, at 28 weeks, and after birth. Access to this injection is limited in developing countries and often not affordable for the average family.ICT test: Indirect Coombs Test, a blood draw on the mother to see if she has red cell antibodies (alloimmunization) which can attack her baby's blood and cause HDFN. This is also called an antibody screen. DCT test: Direct Coombs Test, a blood test that is run on babies after birth to see if mom's antibodies are attaching to their blood cells. A baby with a positive DCT usually means they have hemolytic disease of the fetus and newborn (HDFN).MCA Doppler scan: Specialized ultrasounds that detect fetal anemia. This is the best way to monitor a baby at risk for HDFN to determine if they need an intrauterine blood transfusion to treat their anemia. An MCA value of 1.0 is normal, and 1.5 means the baby is anemic and needs a transfusion. In Kenya, very few hospitals can conduct these MCA Doppler ultrasounds accurately.IUT: Intrauterine transfusion, currently the only way to treat a baby with HDFN in utero. This is a blood transfusion into the baby's umbilical vein using a long needle through the mother's abdomen.Rhesus positive: This means that a person has a positive blood type (D antigen positive). Rose's body is Rhesus negative and makes antibodies to Rhesus positive (D antigen positive) blood. Any donors for her baby would need to be Rhesus negative so that her antibodies do not destroy the newly donated blood.What can you do as a listener?
Please donate to the AHF Africa program. An antibody screen in Kenya costs $5, but most families cannot afford this additional expense. We need $12,000 a year to sustain this program. Learn more about what we do with your donations and make a donation here. Anyone who contributes a $50/month recurring donation will receive quarterly e-mail updates directly from Rose, AHF’s Ambassador to Kenya.Join O Negative Foundation Kenya if you live in Kenya and have a negative blood type.Follow or donate to Rhesus Solution Initiative, a Nigerian NGO dedicated to educating women about their blood type and providing access to Rh immune globulin to prevent alloimmunization.Research for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at https://allohopefoundation.org.
The Allo Podcast is produced and edited by Media Club.
-
Agne’s experience of growing up in the Soviet Union has left her with a vague medical record that doesn’t explain her severe antibody titer affecting her pregnancies. Bethany and Molly experience the culture shock of Agne’s uncommon options following the loss of her first child to a failed intrauterine blood transfusion, followed by two more unthinkable losses as she searches for the information she needs to have her rainbow baby even when it feels impossible.
Show Themes:
Alloimmunization and HDFN treatments in Eastern Europe Parental antigen and antibody status testing Conflicting issues between social views and medical treatment Social customs on discussing loss and pregnancy complications Experiencing the Nipocalimab trial in BelgiumReferences:
Nipocalumab trial Phase 2 resultsNipocalimab trial Phase 3 enrollment updateResearch for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at https://allohopefoundation.org.
The Allo Podcast is produced and edited by Media Club.
-
A powerful episode that you may not know you needed. Bethany and Molly share from the heart in this special episode that will open you up to an awareness and understanding you may not have considered before. Grief and trauma are more common than you think across the motherhood journey, but especially in pregnancies affected by alloimmunization. This episode is intended for any listener who has experienced loss related to pregnancy and motherhood, no matter how big or small, and for those who want to better support a person who has experienced pregnancy trauma and grief. Bethany and Molly share about grief from the loss of a child, and also grief from the loss of expectations, loss of trust, loss of hope for what pregnancy and motherhood would feel like. With the help of insights from previous guests, they discuss a path toward hope and healing the wounds we suffer with loss of a child, the burden of high risk pregnancy, and how to honor our losses.
Show Themes:
Defining trauma and grief: it’s more than pregnancy lossIdentifying the types of trauma with this diseaseHow to find support in times of needSpecific coping tips for loss and griefHow to support a person who has lost a childFinding hope in the darkest momentsLinks:
Why high risk pregnancy causes traumaArticles on Losing Lucy and Finding HopeBooks on finding hope and accepting grief“A Grace Disguised” by Jerry Sittser“An Exact Replica of a Figment of my Imagination” by Elizabeth McCracken“A Grief Observed” by CS Lewis“I Will Carry You” by Angie Smith“A Path through Suffering” by Elisabeth ElliottEffectiveness of a counseling intervention after a traumatic childbirth: a randomized controlled trialIf you or a loved one are having thoughts of suicide contact your national suicide prevention hotline https://988lifeline.org/.
Research for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at https://allohopefoundation.org.
The Allo Podcast is produced and edited by Media Club.
-
The onset of a strange itchiness results in the discovery that pregnant Emily Rusch is experiencing cholestasis. A lack of adequate medical attention results in the death of Emily’s baby in the NICU. Emily shares about her experience as a bereaved and newly sensitized mother as she navigates alloimmunization in her subsequent pregnancies.
Show Themes:
Pregnancy related itching and cholestasis Losing a child Discerning and pursuing medical malpractice litigationFinding ways of maintaining control in difficult situations Advocacy in the NICU and post-discharge for HDFN babiesAnxiety of motherhood and the burden of being your baby’s best advocateReferences:
CholestasisHDFN Newborn calculators and toolsResearch for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at https://allohopefoundation.org
The Allo Podcast is produced and edited by Media Club.
-
Bethany and Molly chat with Dr. Kara Markham, (M.D. University of Cincinnati Medical Center) a maternal fetal medicine specialist and expert in the pregnancy management of alloimmunization and HDFN. They ask questions from the allo community, and end with Bethany and Dr. Markham in a trivia competition about HDFN.
During this grab bag episode, Bethany, Molly and Dr. Markham discuss the following, and more:
Whether antibody titers can be loweredWhether to use Rh immune globulin ("Rhogam") in early pregnancy bleedingCross-matching for more than just the D antigen before transfusionBreastfeeding HDFN babiesChecking titers before pregnancyWhen to do plasmapheresis and IVIGWhen to conduct MCA Doppler ultrasoundsHow to ask for different careResources mentioned in this episode:
AAP guidelines for hyperbilirubinemia: LINKZimmerman et al. study (with Mari) discussing the utility of weekly MCAs in discussion: LINKDr. Markham's paper on women with multiple antibodies: LINKSensitization Rates:Buhari HA, Sagir A, Akuyam SA, Erhabor O, Panti AA. Distribution of Maternal Red Cell Antibodies and the Risk of Haemolytic Disease of the Foetus and Newborn in Sokoto Nigeria. Journal of Complementary and Alternative Medical Research. 2022 Dec 23;20(2):22-9.Fan J, Lee BK, Wikman AT, Johansson S, Reilly M. Associations of Rhesus and non-Rhesus maternal red blood cell alloimmunization with stillbirth and preterm birth. International journal of epidemiology. 2014 Aug 1;43(4):1123-31.Yang EJ, Shin KH, Song D, Lee SM, Kim IS, Kim HH, Lee HJ. Prevalence of unexpected antibodies in pregnant Korean women and neonatal outcomes. The Korean Journal of Blood Transfusion. 2019 Apr 30;30(1):23-32.Research for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at allohopefoundation.org.
The Allo Podcast is produced and edited by https://www.mediaclub.co
-
Amber already had a difficult and rare blood disorder (TTP) but treatment for her unknown disease resulted in her developing antibodies, resulting in alloimmunization in her first pregnancy. A chance visit with a different doctor made the difference with her first child, but extraordinary measures were needed when she became pregnant with twins. Bethany and Molly are in for quite a tale of HDFN in already unusual circumstances.
Show Themes
Pregnancy with secondary diseaseManaging alloimmunization with twinsWhen to get an IUTMaking difficult decisions with twins After birth in the NICU and preemie challengesLinks
TTP information Platelet Disorders - Thrombotic Thrombocytopenic Purpura (TTP) | NHLBI, NIHTTP and Pregnancy TTP and pregnancy | Blood | American Society of Hematology (ashpublications.org)MoM calculator Calculators & Tools - Allo Hope FoundationIUT outcomes with hydrops Liden https://www.sciencedirect.com/science/article/abs/pii/S0002937801313728 Nystagmus Nystagmus: Definition, Causes & Treatment (clevelandclinic.org)NEC Necrotizing Enterocolitis (NEC): What is it, Causes & Treatment (clevelandclinic.org) -
Navigating maternal alloimmunization and having a baby with HDFN is a high-stress, difficult, and sometimes dangerous experience. Sometimes you may want to make a choice to navigate around these difficulties. What are your options? Molly and Bethany discuss options available to Allo moms and families, and Bethany shares her own past experiences considering each option and even attempting adoption. Remember, at the end of the day, the decision is always yours.
Show Themes:
Making the decision to get pregnant again, natural or otherwise. The options:In-vitro fertilization (IVF) with preimplantation genetic diagnosis (PGD) Sperm donationSurrogacyAdoption Embryo adoption Making a personal decision despite outside pressure.Reference:
First cases of IVF with PGD for Antigen selection:PGD for the K antigen in US, 2003: https://www.sciencedirect.com/science/article/pii/S0015028203011567
PGD for the D antigen in Austria, 2005: https://academic.oup.com/humrep/article/20/3/697/2356451?login=false
Inducing lactation protocol for adoptive moms. Induced lactation: Can I breastfeed my adopted baby? - Mayo ClinicThe Heart Gallery https://heartgalleryofamerica.org/More Information:
IUI with sperm donation: https://americanpregnancy.org/getting-pregnant/donor-insemination/ https://www.healthline.com/health/artificial-insemination#successIVF: https://www.nhs.uk/conditions/ivf/PGD: https://www.reproductivefacts.org/news-and-publications/patient-fact-sheets-and-booklets/documents/fact-sheets-and-info-booklets/preimplantation-genetic-testing/Surrogacy: https://my.clevelandclinic.org/health/articles/23186-gestational-surrogacy#:~:text=In%20gestational%20surrogacy%2C%20the%20embryo,starts%20with%20selecting%20a%20carrier. Adoption: https://creatingafamily.org/adoption/resources/Research for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at
https://allohopefoundation.org
The Allo Podcast is produced and edited by Media Club
-
Navigating the American medical system is not new to a clinician like Katie, but experiencing it as a rare disease patient is a different story entirely. This week Bethany and Molly interview Allo Hope Foundation’s Director of Development, Katie Shanahan, a nurse practitioner who became sensitized after not receiving Rh immunoglobulin (RhIG, sometimes called RHOGAM). Her alloimmunization progressed rapidly as her son developed significant HDFN in her first alloimmunized pregnancy. Katie shares stories of IUTs and NICU life in such a relatable and informative way. Also, the women discuss the process of in vitro fertilization and how preimplantation genetic diagnosis can make Katie’s next pregnancy a very different experience.
Show Themes:
Low titer progressing to severe diseaseFirst alloimmunized pregnancyIUT protocols and timingNICU experience Grief and traumaReflecting on daily life after an alloimmunized pregnancyIn vitro fertilization (IVF) using preimplantation genetic diagnosis (PGD) to have an antigen negative babyReference
Study about missed Rhogam https://www.sciencedirect.com/science/article/pii/S2666577821000368More information about cffDNA testing through the Unity Screen https://unityscreen.com/conditions-fetal-antigens/ or Sanquin Laboratories https://www.sanquin.org/products-and-services/diagnostics/non-invasive-fetal-blood-group-genotyping Fetal outcomes are improved if IUTs are conducted before signs of hydrops https://www.sciencedirect.com/science/article/abs/pii/S0002937801313728 Use of erythropoietin (EPO) in newborns with HDFN review https://www.sciencedirect.com/science/article/abs/pii/S0378378211002337 and ongoing clinical trial https://scholarlypublications.universiteitleiden.nl/access/item%3A3284942/downloadResearch for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at https://allohopefoundation.org
The Allo Podcast is produced and edited by Media Club
-
In this episode, Bethany and Molly focus on obstetricians and other medical professionals who play the critical role of diagnosis and initial treatment planning for alloimmunized patients. To close, Bethany and Molly play a game to try to treatment plan for alloimmunized patients based on limited information, and find a new level of appreciation for physicians.
Show themes
Telling a patient they have maternal alloimmunization: what every patient wishes they could hearMost important initial blood tests and their implicationsDetermining how quickly a patient should see a high risk doctorThe importance of finding the right MFM, not the nearest MFMReference
ACOG conference information ACOG Annual Clinical & Scientific MeetingHow to get a Allo Hope Foundation Patient Booklet Booklets - Allo Hope FoundationACOG’s list of antibodies known to cause HDFN Management of Alloimmunization During Pregnancy | ACOGMFM provider checklist Provider Checklist - Allo Hope FoundationACOG guidelines for Late Preterm/Early Term Deliveries Medically Indicated Late-Preterm and Early-Term Deliveries | ACOGResearch for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at https://allohopefoundation.org
The Allo Podcast is produced and edited by Media Club
-
Welcome back to Season 2 of The Allo Podcast. Bethany and Molly return and begin the season with Brittany Pineda, an incredible mother whose antibodies were missed in her first two alloimmunized pregnancies. After suffering the loss of her son Kristian, she shares a story of hope as she stops at nothing to get the care she needed even with extremely aggressive disease. Brittany’s story demonstrates how doctors across multiple states can come together to create a comprehensive and effective treatment plan for even the most complicated situation.
Show Themes:
Red flags in treatmentFetal lossWhen to find second opinionsSevere HDFN (early onset)Plasmapheresis and IVIG for severe diseaseCoordination of care across multiple providersNICU experiencesIron chelation therapy in HDFN newborns with extremely high ironLinks:
Study about missed Rhogam https://www.sciencedirect.com/science/article/pii/S2666577821000368
MFM question checklist Provider Checklist - Allo Hope Foundation
Fetal outcomes are improved if IUTs are conducted before signs of hydrops https://www.sciencedirect.com/science/article/abs/pii/S0002937801313728
Research for this episode provided by Bethany Weathersby and Molly Sherwood of the Allo Hope Foundation. Find more information at https://allohopefoundation.org
The Allo Podcast is produced and edited by Media Club
- Daha fazla göster
